CM
NEO icon

Caption Management’s NeoGenomics NEO Stock Holding History

Caption Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,705
Closed -$379K – 1709
2024
Q3 		$379K Buy
+25,705
New +$402K 0.01% 978
2022
Q4 		– Sell
-34,700
Closed -$298K – 1578
2022
Q3 		$298K Buy
+34,700
New +$345K ﹤0.01% 1185
2021
Q4 		– Sell
-7,200
Closed -$347K – 1827
2021
Q3 		$347K Buy
+7,200
New +$333K ﹤0.01% 1265

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Caption Management's NEO Position: Q4 2024 in Review

Caption Management sold out of NeoGenomics (NEO) in Q4 2024, closing a stake of 25,705 shares — an estimated $379K sold.

Caption Management first reported a position in NEO in Q3 2021 and held it in 3 quarters. The position peaked at $379K in Q3 2024. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.

  • Caption Management reported no remaining NeoGenomics position as of Q4 2024 after selling out during the quarter.
  • Caption Management sold 25,705 NeoGenomics shares in Q4 2024, an estimated $379K.
  • Caption Management first reported a position in NeoGenomics in Q3 2021 and held it in 3 quarters.
  • Caption Management's NeoGenomics position peaked at $379K in Q3 2024.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.

Based on Caption Management's 13F filing for Q4 2024, filed 14 Feb 2025.